#3 Clinical Trend: Cologuard
Cologuard was recently approved by the US Food and Drug Administration (FDA) as a stool-based colorectal cancer screening tool. It analyzes specimens to detect hemoglobin, multiple DNA methylation and mutational markers, and the total amount of human DNA contained in cells that are shed by colorectal carcinomas or advanced adenomas into the colon.
For more in-depth clinical information, see Colon Cancer.
Medscape © 2014 WebMD, LLC
Cite this: Top 10 Trends in Medicine, September 2014 - Medscape - Sep 23, 2014.